Skip to Main Content

Paper Details

Association of glycated hemoglobin A1c levels with cardiovascular outcomes in the general population: results from the BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) consortium.
Cardiovasc Diabetol
18
2021
CVD, CVRFs, Glycated hemoglobin A1c, HbA1c, cardiovascular, cardiovascular disease, diabetes, glycated hemoglobin A1c, participants
Author NameAffiliation
Henry V??lzkeDepartment of Study of Health in Pomerania/Clinical-Epidemiological Research, Institute for Community Medicine, University Medicine Greifswald
Henry V??lzkeGerman Center for Cardiovascular Research (DZHK)
Henry V??lzkeDepartment of Study of Health in Pomerania/Clinical-Epidemiological Research, Institute for Community Medicine, University Medicine Greifswald
Henry V??lzkeGerman Center for Cardiovascular Research (DZHK)
Annette PetersGerman Research Center for Environmental Health, Institute of Epidemiology
Annette PetersGerman Research Center for Environmental Health, Institute of Epidemiology
Wolfgang RathmannInstitute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University
Wolfgang RathmannInstitute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University
Kari KuulasmaaFinnish Institute for Health and Welfare
Inger NjølstadUiT The Arctic University of Norway
Tom WilsgaardUiT The Arctic University of Norway
Stefan BlankenbergUniversity Heart & Vascular Center Hamburg
Stefan BlankenbergGerman Center for Cardiovascular Research (DZHK)
Marco M FerrarioEPIMED Research Center, University of Insubria at Varese
Barbara ThorandGerman Research Center for Environmental Health, Institute of Epidemiology
Barbara ThorandGerman Center for Diabetes Research (DZD)
  • 1 - 16

Datasets

Release 1.2